EpitopeX

Biotechnology
Active
Tel Aviv, Israel Founded 2026
Last updated 2026-08-29
Total raised
$107.2M
Stage
—
Founded
2026
Headcount
—
HQ
Tel Aviv, Israel
Sector
Biotechnology

Funding history · 5 rounds · $107.2M total

5 events/rounds · $107.2M Total Funding: $98.6M in Private Equity
Jul 2026
Grant $8.6M calcalistech.com ↗
★ European Union's Horizon Europe program
Jun 2026
C Round $2.2M eqs-news.com ↗
★ Caesar Ventures★ XISTA Science VenturesNavec Venture Holding GmbHAustria Wirtschaftsservice (AWS)Austrian Research Promotion Agency (FFG)FFG (Austrian Research Promotion Agency)Austrian federal development and financing bank AWSAWS (Austrian federal development and financing bank)
Jan 2026
Oct 2024
A Round Extension $31.0M epitopea.com ↗
★ Jonathan Milner★ CTI Life Sciences★ Advent Life Sciences★ Investissement Québec★ adMare BioInnovations★ Fonds de Solidarité FTQ★ Cambridge Innovation Capital★ Harrington Discovery InstituteIRICoRNovateur Ventures
Mar 2023

Offices

Tel Aviv, Israel · HQ / main office

Q&A

What is EpitopeX's primary sector?
EpitopeX's primary sector is Biotechnology.
Where is EpitopeX headquartered?
EpitopeX is headquartered in Tel Aviv, Israel.
What are the key sub-sectors EpitopeX operates in?
EpitopeX operates in the Immunology and Vaccine Development sub-sectors.
What technologies does EpitopeX focus on?
EpitopeX focuses on Epitope Mapping and Antibody Technology.
Who are EpitopeX's target customers?
EpitopeX's target customers are Pharmaceutical Companies and Research Institutions.
What are EpitopeX's target markets?
EpitopeX's target markets are Therapeutics and Vaccines.

Sectors & technology

Primary sector
Biotechnology
Technologies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2026